Latest news with #MethodeElectronics
Business Upturn
17-06-2025
- Business
- Business Upturn
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of Maison Solutions Inc. (NASDAQ
PHILADELPHIA, June 17, 2025 (GLOBE NEWSWIRE) — Maison Solutions Inc. (NASDAQ: MSS) Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Maison Solutions Inc. (NASDAQ: MSS) as an underlying securities fraud class action has survived a motion to dismiss the complaint. If you are a current Maison Solutions Inc. (NASDAQ: MSS) shareholder who purchased Maison shares on or near its October 5, 2023 IPO, you can seek corporate reforms, the return of money back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit contact Joshua Grabar at [email protected] or call us at 267-507-6085 WHY? An underlying securities fraud class action complaint alleges that in Maison Solutions Inc.'s (NASDAQ: MSS) IPO Registration Statement and throughout the Class Period (October 5, 2023 through December 15, 2023), Maison, through certain of its officers, made materially false and/or misleading statements, including failing to disclose to investors: (1) that the Company's vendor XHJC Holdings Inc., is a related party; (2) that the Company's CEO and related entities were alleged to have used supermarkets as a front to defraud the EB-5 visa program; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. On March 31, 2025, material portions of the underlying securities fraud complaint survived a motion to dismiss. WHAT YOU CAN DO NOW: If you purchased Maison Solutions Inc. (NASDAQ: MSS) shares on or near its October 5, 2023 IPO and still hold shares today, you are encouraged to visit contact Joshua Grabar at [email protected] , or call 267-507-6085. You may be able to seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. $MSS #MaisonSolutions Methode Electronics, Inc. (NYSE: MEI): Current Methode Electronics, Inc. (NYSE: MEI) shareholders who have held Methode Electronics shares since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award – all at no cost to them whatsoever. To learn more visit: contact Joshua Grabar at [email protected], or call 267-507-6085. Why: A recently filed underlying securities fraud class action complaint alleges that Methode Electronics, via certain of its officers and directors, made false and/or misleading statements and/or failed to disclose that: (i) Methode Electronics had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete Methode Electronics' transition from its historic low mix, high volume production model to a high mix, low production model at its Monterrey facility; (ii) Methode Electronics' attempts to replace its General Motors center console production with more diversified, specialized products for a wider array of vehicle manufacturers and OEMs, in particular in the electric vehicle ('EV') space, had been plagued by production planning deficiencies, inventory shortages, vendor and supplier problems, and, ultimately, botched execution of Methode Electronics' strategic plans; (iii) Methode Electronics' manufacturing systems at its critical Monterrey facility suffered from a variety of logistical defects, such as improper system coding, shipping errors, erroneous delivery times, deficient quality control systems, and failures to timely and efficiently procure necessary raw materials; (iv) Methode Electronics had fallen substantially behind on the launch of new EV programs out of its Monterrey facility, preventing Methode Electronics from timely receiving revenue from new EV program awards; and (v) as a result, Methode Electronics was not on track to achieve the 2023 diluted earnings-per-share guidance or the 3-year 6% organic sales compound annual growth rate represented to investors and such estimates lacked a reasonable factual basis. What You Can Do Now: Current Methode Electronics shareholders who have held Methode Electronics stock since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter, you are encouraged to visit contact Joshua Grabar at [email protected], or call 267-507-6085. #Methode #MethodeElectronics $MEI Treace Medical Concepts, Inc. (NASDAQ: TMCI) If you have held Treace Medical Concepts (NASDAQ: TMCI) shares continuously since prior to May 8, 2023, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you. Visit or contact Joshua H. Grabar at [email protected] or call 267-507-6085 to learn more. Why? A recently filed securities class action complaint alleges that, Treace Medical Concepts, Inc. (NASDAQ: TMCI), via certain of its officers, made materially false and/or misleading statements and failed to disclose adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System; (2) as a result, Treace Medical's revenue declined, and the Company needed to accelerate its plans to offer a product that served as an alternative to osteotomy (a surgical procedure involving the cutting and realignment of a bone to improve its position or function); and (3) Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. What You Can Do Now: Current Treace shareholders who have held Treace shares since prior to May 8, 2023, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter, you are encouraged to visit contact us at [email protected], or call 267-507-6085. #Treace $TMCI Xponential Fitness Inc. (NYSE: XPOF): Current Xponential Fitness Inc. (NYSE: XPOF) shareholders who have continuously held Xponential shares since on or shortly after the company's July 2021 IPO, can seek corporate reforms, the return of funds back to company coffers, and a court approved incentive award at no cost to them whatsoever. Learn more or join by Clicking email Joshua Grabar at [email protected], or call us at 267-507-6085. WHAT IS HAPPENING: Grabar Law Office is investigating claims on behalf of long-term Xponential shareholders. The investigation concerns whether certain officers of the company have breached their fiduciary duties owed to the company. BASIS OF THE INVESTIGATION: A securities fraud class action lawsuit has been filed that alleges that Xponential Fitness (NYSE: XPOF), through certain of its officers and directors, made false and misleading statements or failed to disclose that: (1) Xponential had permanently closed at least 30 stores; (2) Xponential's reported same-store sales and average unit volume metrics had been misstated by excluding underperforming stores; (3) 8 out of 10 Xponential brands were losing money monthly; (4) over 50% of Xponential studios did not make a positive financial return; (5) over 60% of Xponential's revenue was one-time and non-recurring; (6) more than 100 of Xponential's franchises were for sale at a price that is at least 75% less than their initial cost; (7) Xponential had misled many of its franchisees into opening franchises by misrepresenting the financial profile and profitability of its studios, as well as the expected rate of return for new studio openings; (8) many Xponential franchisees were substantially in debt, suffering high attrition rates and running non-viable studios that had no realistic path to profitability; and (9) based on the foregoing, defendants lacked a reasonable factual basis for their positive statements about Xponential's then-current business operations and future financial prospects. YOUR RIGHTS: Current Xponential Fitness shareholders who have held Xponential Fitness shares since on or shortly after the company's July 2021 IPO can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter or join it, you are encouraged to visit contact Joshua H. Grabar at [email protected], or call 267-507-6085. $XPOF #XponentialFitness Attorney Advertising Disclaimer Contact:Joshua H. Grabar, Law OfficeOne Liberty Place1650 Market Street, Suite 3600Philadelphia, PA 19103Tel: 267-507-6085 Email: [email protected]
Yahoo
16-06-2025
- Business
- Yahoo
Byrna, Methode Electronics, Globalstar, Amplitude, and Dine Brands Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices rebounded (Nasdaq +1.5%, S&P 500 +1.0%) as reports pointed to easing tensions between Israel and Iran. The Wall Street Journal said senior Iranian officials had signaled a willingness to restart stalled nuclear talks, on the condition that Washington refrain from joining Israel's ongoing strikes. This development triggered a significant decline in oil prices, easing inflation concerns. Also, it is possible some investors were buying the dip following the sell-off at the end of the previous week. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Law Enforcement Suppliers company Byrna (NASDAQ:BYRN) jumped 6.7%. Is now the time to buy Byrna? Access our full analysis report here, it's free. Electrical Systems company Methode Electronics (NYSE:MEI) jumped 6.6%. Is now the time to buy Methode Electronics? Access our full analysis report here, it's free. Satellite Telecommunication Services company Globalstar (NASDAQ:GSAT) jumped 5.5%. Is now the time to buy Globalstar? Access our full analysis report here, it's free. Data Analytics company Amplitude (NASDAQ:AMPL) jumped 5.2%. Is now the time to buy Amplitude? Access our full analysis report here, it's free. Sit-Down Dining company Dine Brands (NYSE:DIN) jumped 5%. Is now the time to buy Dine Brands? Access our full analysis report here, it's free. Byrna's shares are extremely volatile and have had 74 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business. The previous big move we wrote about was 20 days ago when the stock gained 5.9% on the news that the major indices rebounded (Nasdaq +2.0%, S&P 500 +1.5%) as President Trump postponed the planned 50% tariff on European Union imports, shifting the start date to July 9, 2025. Companies with substantial business ties to Europe likely had some relief as the delay reduced near-term cost pressures and preserved cross-border demand. Byrna is up 10.9% since the beginning of the year, and at $31.42 per share, it is trading close to its 52-week high of $34.19 from February 2025. Investors who bought $1,000 worth of Byrna's shares 5 years ago would now be looking at an investment worth $2,123. Today's young investors likely haven't read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
Associated Press
16-05-2025
- Business
- Associated Press
Alert: Grabar Law Office is Investigating Claims on Behalf Long-Term Shareholders of Methode Electronics, Inc. (NYSE: MEI); Treace Medical Concepts, Inc. (NASDAQ: TMCI); Virtu Financial Inc. (NASDAQ: VIRT); and West Pharmaceutical Services, Inc.
PHILADELPHIA, May 16, 2025 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI): Current Methode Electronics, Inc. (NYSE: MEI) shareholders who have held Methode Electronics shares since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award - all at no cost to them whatsoever. To learn more visit: contact Joshua Grabar at [email protected], or call 267-507-6085. Why: A recently filed underlying securities fraud class action complaint alleges that Methode Electronics, via certain of its officers and directors, made false and/or misleading statements and/or failed to disclose that: (i) Methode Electronics had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete Methode Electronics' transition from its historic low mix, high volume production model to a high mix, low production model at its Monterrey facility; (ii) Methode Electronics' attempts to replace its General Motors center console production with more diversified, specialized products for a wider array of vehicle manufacturers and OEMs, in particular in the electric vehicle ('EV') space, had been plagued by production planning deficiencies, inventory shortages, vendor and supplier problems, and, ultimately, botched execution of Methode Electronics' strategic plans; (iii) Methode Electronics' manufacturing systems at its critical Monterrey facility suffered from a variety of logistical defects, such as improper system coding, shipping errors, erroneous delivery times, deficient quality control systems, and failures to timely and efficiently procure necessary raw materials; (iv) Methode Electronics had fallen substantially behind on the launch of new EV programs out of its Monterrey facility, preventing Methode Electronics from timely receiving revenue from new EV program awards; and (v) as a result, Methode Electronics was not on track to achieve the 2023 diluted earnings-per-share guidance or the 3-year 6% organic sales compound annual growth rate represented to investors and such estimates lacked a reasonable factual basis. What You Can Do Now: Current Methode Electronics shareholders who have held Methode Electronics stock since prior to June 23, 2022, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter, you are encouraged to visit contact Joshua Grabar at [email protected], or call 267-507-6085. #Methode #MethodeElectronics $MEI Treace Medical Concepts, Inc. (NASDAQ: TMCI) If you have held Treace Medical Concepts (NASDAQ: TMCI) shares continuously since prior to May 8, 2023, you can seek corporate reforms, the return of funds back to the Company, and a court approved incentive award at no cost you. Visit or contact Joshua H. Grabar at [email protected] or call 267-507-6085 to learn more. Why? A recently filed securities class action complaint alleges that, Treace Medical Concepts, Inc. (NASDAQ: TMCI), via certain of its officers, made materially false and/or misleading statements and failed to disclose adverse facts about the Company's business, operations, and prospects. Specifically, the Complaint alleges Defendants failed to disclose that: (1) competition impacted the demand for and utilization of its primary product, the Lapiplasty 3D Bunion Correction System; (2) as a result, Treace Medical's revenue declined, and the Company needed to accelerate its plans to offer a product that served as an alternative to osteotomy (a surgical procedure involving the cutting and realignment of a bone to improve its position or function); and (3) Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis. What You Can Do Now: Current Treace shareholders who have held Treace shares since prior to May 8, 2023, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. If you would like to learn more about this matter, you are encouraged to visit contact us at [email protected], or call 267-507-6085. #Treace $TMCI Virtu Financial Inc. (NASDAQ: VIRT) Class Action Survives Motion to Dismiss: A federal securities fraud class action complaint alleging that Virtu Financial Inc. (NASDAQ: VIRT), and certain of its officers failed to disclose to investors that it had improper safeguards in place for sensitive trader information, has survived a motion to dismiss. Virtu shareholders who have continuously held Virtu shares since prior to November 7, 2018, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them whatsoever. Learn more or join by clicking contact Joshua H. Grabar at [email protected], or call 267-507-6085. WHY: A securities fraud class action complaint alleges that Virtu Financial (NASDAQ: VIRT), via certain of its officers, made false and/or misleading statements and/or failed to disclose that: (i) the Company maintained deficient policies and procedures with respect to its information access barriers; (ii) accordingly, Virtu had overstated the Company's operational and technological efficacy as well as its capacity to block the exchange of confidential information between departments or individuals within the Company; (iii) the foregoing deficiencies increased the likelihood that the Company would be subject to enhanced regulatory scrutiny; and (iv) as a result, Defendants' public statements were materially false and/or misleading at all relevant times. On March 17, 2025, a federal Court determined that key allegations were sufficiently pled to survive defendants' motion to dismiss. According to the Court's Order, 'essentially anyone at Virtu, including its proprietary traders' could directly access this material non-public information from at least January 2018 through April 2019, and to do so, Virtu traders only needed to use a 'widely known and frequently shared username and password.' WHAT YOU SHOULD DO NOW: If you are a current Virtu shareholder who has held Virtu stock since on or before November 7, 2018, you can seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to you whatsoever. If you would like to learn more about this matter, you are encouraged visit contact Joshua H. Grabar at [email protected] or call 267-507-6085. $VIRT #VirtuFinancial West Pharmaceutical Services, Inc. (NYSE: WST) Grabar Law Office is investigating whether certain officers and directors of West Pharmaceutical Services, Inc. (NYSE: WST) breached the fiduciary duties they owed to the company. If you are a long-term West shareholder who has held West shares since before February 16, 2023, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Visit or contact Joshua Grabar at [email protected], or 267-507-6048 to learn more. Why? An underlying securities fraud class action complaint alleges that West, via certain of its officers, failed to disclose that: (a) while claiming strong visibility into customer demand and attributing headwinds to temporary COVID-related product destocking, West was in fact experiencing significant and ongoing destocking across its high-margin High-Value Products portfolio; (b) West's SmartDose device, which was purportedly positioned as a high-margin growth product, was highly dilutive to the Company's profit margins due to operational inefficiencies; (c) these margin pressures created the risk of costly restructuring activities, including the Company's exit from continuous glucose monitoring contracts with long-standing customers; and (d) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially false and/or misleading or lacked a reasonable basis. As alleged in the underlying class action complaint, the truth about the fraud was revealed with a series of disclosures culminating on February 13, 2025, when West issued extremely weak 2025 revenue and earnings forecasts. West attributed the disappointing guidance in part to contract manufacturing headwinds, including the loss of two major continuing glucose monitoring customers that had begun transitioning to in-house manufacturing of next-generation devices after West 'made the decision to not participate going forward as our financial thresholds cannot be achieved.' West also revealed that its SmartDose wearable injector devices would be 'margin-dilutive' in 2025 and that it would be 'taking steps to improve [its SmartDose] economics, and all options are on the table.' On this news, West's stock dropped 38 percent. What You Can Do Now: Current West shareholders who have continuously held West stock since prior to February 16, 2023, can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to them. If you would like to learn more about this matter at no cost to you, you are encouraged to visit contact Joshua H. Grabar at [email protected], or call 267-507-6085. #WestPharmaceutical #WST Attorney Advertising Disclaimer Contact: Joshua H. Grabar, Esq. Grabar Law Office One Liberty Place 1650 Market Street, Suite 3600 Philadelphia, PA 19103 Tel: 267-507-6085 Email: [email protected]
Yahoo
16-04-2025
- Business
- Yahoo
Electrical Systems Stocks Q4 Teardown: Vertiv (NYSE:VRT) Vs The Rest
As the Q4 earnings season wraps, let's dig into this quarter's best and worst performers in the electrical systems industry, including Vertiv (NYSE:VRT) and its peers. Like many equipment and component manufacturers, electrical systems companies are buoyed by secular trends such as connectivity and industrial automation. More specific pockets of strong demand include Internet of Things (IoT) connectivity and the 5G telecom upgrade cycle, which can benefit companies whose cables and conduits fit those needs. But like the broader industrials sector, these companies are also at the whim of economic cycles. Interest rates, for example, can greatly impact projects that drive demand for these products. The 13 electrical systems stocks we track reported a slower Q4. As a group, revenues were in line with analysts' consensus estimates while next quarter's revenue guidance was 6% below. Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 23.9% since the latest earnings results. Formerly part of Emerson Electric, Vertiv (NYSE:VRT) manufactures and services infrastructure technology products for data centers and communication networks. Vertiv reported revenues of $2.35 billion, up 25.8% year on year. This print exceeded analysts' expectations by 8.8%. Overall, it was a very strong quarter for the company with an impressive beat of analysts' organic revenue and EBITDA estimates. 'Data centers are crucial for meeting the world's digital demands,' said Giordano Albertazzi, Vertiv's Chief Executive Officer. The stock is down 42.8% since reporting and currently trades at $70.50. Read why we think that Vertiv is one of the best electrical systems stocks, our full report is free. Enhancing commercial environments, LSI (NASDAQ:LYTS) provides lighting and display solutions for businesses and retailers. LSI reported revenues of $147.7 million, up 35.5% year on year, outperforming analysts' expectations by 14.3%. The business had an incredible quarter with an impressive beat of analysts' EPS estimates and a solid beat of analysts' EBITDA estimates. LSI delivered the biggest analyst estimates beat and fastest revenue growth among its peers. The stock is down 24.2% since reporting. It currently trades at $15.01. Is now the time to buy LSI? Access our full analysis of the earnings results here, it's free. Founded in 1946, Methode Electronics (NYSE:MEI) is a global supplier of custom-engineered solutions for Original Equipment Manufacturers (OEMs). Methode Electronics reported revenues of $239.9 million, down 7.6% year on year, falling short of analysts' expectations by 8.9%. It was a disappointing quarter as it posted revenue guidance for next quarter missing analysts' expectations. Methode Electronics delivered the weakest performance against analyst estimates in the group. As expected, the stock is down 48.6% since the results and currently trades at $5.05. Read our full analysis of Methode Electronics's results here. Credited with introducing the first automatic washing machine, Whirlpool (NYSE:WHR) is a manufacturer of a variety of home appliances. Whirlpool reported revenues of $4.14 billion, down 18.7% year on year. This print lagged analysts' expectations by 1.5%. Overall, it was a disappointing quarter as it also produced full-year EPS guidance missing analysts' expectations. Whirlpool had the slowest revenue growth among its peers. The stock is down 39.3% since reporting and currently trades at $78.55. Read our full, actionable report on Whirlpool here, it's free. A respected player in the electrical segment, Hubbell (NYSE:HUBB) manufactures electronic products for the construction, industrial, utility, and telecommunications markets. Hubbell reported revenues of $1.33 billion, flat year on year. This number missed analysts' expectations by 4.8%. It was a slower quarter as it also recorded a miss of analysts' organic revenue and EBITDA estimates. The stock is down 16% since reporting and currently trades at $343.10. Read our full, actionable report on Hubbell here, it's free. As a result of the Fed's rate hikes in 2022 and 2023, inflation has come down from frothy levels post-pandemic. The general rise in the price of goods and services is trending towards the Fed's 2% goal as of late, which is good news. The higher rates that fought inflation also didn't slow economic activity enough to catalyze a recession. So far, soft landing. This, combined with recent rate cuts (half a percent in September 2024 and a quarter percent in November 2024) have led to strong stock market performance in 2024. The icing on the cake for 2024 returns was Donald Trump's victory in the U.S. Presidential Election in early November, sending major indices to all-time highs in the week following the election. Still, debates around the health of the economy and the impact of potential tariffs and corporate tax cuts remain, leaving much uncertainty around 2025. Want to invest in winners with rock-solid fundamentals? Check out our Hidden Gem Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Join Paid Stock Investor Research Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.
Yahoo
14-04-2025
- Business
- Yahoo
Q4 Earnings Highs And Lows: Sanmina (NASDAQ:SANM) Vs The Rest Of The Electrical Systems Stocks
Looking back on electrical systems stocks' Q4 earnings, we examine this quarter's best and worst performers, including Sanmina (NASDAQ:SANM) and its peers. Like many equipment and component manufacturers, electrical systems companies are buoyed by secular trends such as connectivity and industrial automation. More specific pockets of strong demand include Internet of Things (IoT) connectivity and the 5G telecom upgrade cycle, which can benefit companies whose cables and conduits fit those needs. But like the broader industrials sector, these companies are also at the whim of economic cycles. Interest rates, for example, can greatly impact projects that drive demand for these products. The 13 electrical systems stocks we track reported a slower Q4. As a group, revenues were in line with analysts' consensus estimates while next quarter's revenue guidance was 6.1% below. Amidst this news, share prices of the companies have had a rough stretch. On average, they are down 20.3% since the latest earnings results. Founded in 1980, Sanmina (NASDAQ:SANM) is an electronics manufacturing services company offering end-to-end solutions for various industries. Sanmina reported revenues of $2.01 billion, up 7% year on year. This print exceeded analysts' expectations by 1.5%. Despite the top-line beat, it was still a mixed quarter for the company with a decent beat of analysts' EPS estimates but EPS guidance for next quarter missing analysts' expectations significantly. "We delivered solid first quarter financial results, with revenue towards the high end and non-GAAP earnings per share exceeding our outlook. We continue to execute well, as evident in our consistent operating margin and cash generation," stated Jure Sola, Chairman and Chief Executive Officer of Sanmina Corporation. The market was likely pricing in the results, and the stock is flat since reporting. It currently trades at $78.42. Read our full report on Sanmina here, it's free. Enhancing commercial environments, LSI (NASDAQ:LYTS) provides lighting and display solutions for businesses and retailers. LSI reported revenues of $147.7 million, up 35.5% year on year, outperforming analysts' expectations by 14.3%. The business had an incredible quarter with a solid beat of analysts' EPS estimates and an impressive beat of analysts' EBITDA estimates. LSI achieved the biggest analyst estimates beat and fastest revenue growth among its peers. The stock is down 10.7% since reporting. It currently trades at $17.69. Is now the time to buy LSI? Access our full analysis of the earnings results here, it's free. Founded in 1946, Methode Electronics (NYSE:MEI) is a global supplier of custom-engineered solutions for Original Equipment Manufacturers (OEMs). Methode Electronics reported revenues of $239.9 million, down 7.6% year on year, falling short of analysts' expectations by 8.9%. It was a disappointing quarter as it posted revenue guidance for next quarter missing analysts' expectations. Methode Electronics delivered the weakest performance against analyst estimates in the group. As expected, the stock is down 48% since the results and currently trades at $5.11. Read our full analysis of Methode Electronics's results here. Originally a metal-working shop supporting local petrochemical facilities, Powell (NYSE:POWL) has grown from a small Houston manufacturer to a global provider of electrical systems. Powell reported revenues of $241.4 million, up 24.4% year on year. This number topped analysts' expectations by 3.8%. Taking a step back, it was a satisfactory quarter as it also produced a decent beat of analysts' EPS estimates but a significant miss of analysts' EBITDA estimates. The stock is down 28% since reporting and currently trades at $176.11. Read our full, actionable report on Powell here, it's free. Founded in 1961, Kimball Electronics (NYSE:KE) is a global contract manufacturer specializing in electronics and manufacturing solutions for automotive, medical, and industrial markets. Kimball Electronics reported revenues of $357.4 million, down 15.2% year on year. This print missed analysts' expectations by 0.7%. Overall, it was a softer quarter as it also recorded full-year revenue guidance missing analysts' expectations and a significant miss of analysts' EBITDA estimates. Kimball Electronics had the weakest full-year guidance update among its peers. The stock is down 24.1% since reporting and currently trades at $13.57. Read our full, actionable report on Kimball Electronics here, it's free. Thanks to the Fed's rate hikes in 2022 and 2023, inflation has been on a steady path downward, easing back toward that 2% sweet spot. Fortunately (miraculously to some), all this tightening didn't send the economy tumbling into a recession, so here we are, cautiously celebrating a soft landing. The cherry on top? Recent rate cuts (half a point in September 2024, a quarter in November) have propped up markets, especially after Trump's November win lit a fire under major indices and sent them to all-time highs. However, there's still plenty to ponder — tariffs, corporate tax cuts, and what 2025 might hold for the economy. Want to invest in winners with rock-solid fundamentals? Check out our Top 6 Stocks and add them to your watchlist. These companies are poised for growth regardless of the political or macroeconomic climate. Join Paid Stock Investor Research Help us make StockStory more helpful to investors like yourself. Join our paid user research session and receive a $50 Amazon gift card for your opinions. Sign up here.
